# AngelMed for Early Recognition and Treatment of STEMI

> **NCT00781118** · PHASE3 · COMPLETED · sponsor: **Angel Medical Systems** · enrollment: 1020 (actual)

## Conditions studied

- Acute Myocardial Infarction (AMI)
- Coronary Occlusion
- Acute Coronary Syndrome

## Interventions

- **DEVICE:** Guardian System

## Key facts

- **NCT ID:** NCT00781118
- **Lead sponsor:** Angel Medical Systems
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2014-05-01
- **Final completion:** 2017-05-17
- **Target enrollment:** 1020 (ACTUAL)
- **Last updated:** 2018-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00781118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00781118, "AngelMed for Early Recognition and Treatment of STEMI". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00781118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*